
Canada · Research startup
Chemical.AI is an artificial intelligence company founded in 2018 that focuses on transforming chemical synthesis through AI and advanced reaction informatics.
Funding reportedLast round: Series B
Chemical.AI is an artificial intelligence company founded in 2018 that focuses on transforming chemical synthesis through AI and advanced reaction informatics.
The company aims to enhance drug discovery and molecular innovation by providing AI-powered solutions that streamline the planning, execution, and optimization of chemical synthesis. It collaborates with over 100 companies and research institutes, leveraging proprietary algorithms and extensive chemical data to improve synthesis strategies and productivity. The core offering of Chemical.AI includes the ChemAI Solution system, which features components like ChemAIRS, an AI-powered retrosynthesis platform that generates diverse synthesis routes, and ChemAIOS, an integrated operating system for chemical synthesis. The company also provides IoT-enabled automation solutions for laboratories. Chemical.AI serves a variety of sectors, including pharmaceuticals, biotech, and contract research organizations, and has established partnerships with major firms like Pfizer and NovAliX to advance AI-driven pharmaceuticals.
Funding, as reported
What they build
Known for
cost-effective synthesishigh-throughput reaction screeningsynthetic pathway analysisbiotechnology researchreaction condition risk alertsreaction informaticsretrosynthetic analysisreaction scalability toolsreaction impurity analysisimpurity predictionreaction pathway optimizationinformation technology & servicesscalability analysisai-driven synthesis planningreaction risk assessmentretrosynthesis
Built with from their website
parallax.jsjQuery CDNSquarespace ECommerceAirFont AwesomeCloudFlareViewport MetacdnjsPriority HintsGoogle Font API
Magento 2HSTSAlibaba CloudMobile FriendlyMagento Open SourceSquarespace CommerceOpen GraphjQuery
Add your raise, your deck and your story, and put chemical.ai in front of investors. Or tell us what we have wrong.